Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 79
Selected: 0
NCT IDTitle
NCT03697109A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
NCT07259317Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
NCT03604198Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
NCT02663609Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome
NCT03674814Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer
NCT06495944Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants
NCT00936741An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
NCT00146523An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
NCT00130676A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression
NCT03877952Mass Balance Recovery and Metabolite Profile of CORT125281 in Healthy Male Participants
NCT06094712A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male Subjects
NCT04329949Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
NCT04990310Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants
NCT03823703Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)
NCT07276373Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
NCT06928779Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant
NCT05257408Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
NCT06094725A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Relacorilant
NCT00569582A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
NCT00752843A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers
NCT03258372Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites
NCT03540836A Study to Determine the Relative Bioavailability of Two New Relacorilant Capsule Variants
NCT03067376A Study Designed to See How [14C]-CORT125134 is Taken up, Broken Down and Removed From the Body
NCT06094790A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects
NCT00455442A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain
NCT05772169Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
NCT02014337Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
NCT07553663Evaluating the Pharmacokinetics and Safety of Miricorilant
NCT03379363Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome
NCT03818256A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications
NCT07240116Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects
NCT04672499Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants
NCT03315338First-in-human Study in Healthy Subjects
NCT06099769A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
NCT00128505An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
NCT03437941Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT01925092Mifepristone in Children With Refractory Cushing's Disease
NCT00208156A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
NCT02762981Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors
NCT02804750Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
NCT06947304Evaluation of Miricorilant on Liver Fat in Patients With MASLD
NCT00698022A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers
NCT03878264Absolute Bioavailability and Metabolism Study of CORT118335 in Healthy Male Participants
NCT01371565Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
NCT03508635CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
NCT00128479A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
NCT03512548Study in Healthy Subjects to Determine the Effect of an Inhibitor on Exposure to Relacorilant and Its Metabolites
NCT03442621Relacorilant Food Effect Study in Healthy Subjects
NCT05217758RESET-medication Glucocorticoid Receptor (GR) Blockade As Disease Modifying Treatment for Depression with Childhood Trauma
NCT02642939Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer